Read article – Quotes Mark Hiatt, clinical assistant professor of psychiatry, in a feature story about a New York Times video op-ed by Olympian Alexi Pappas’12 in which she discussed her experience with clinical depression. “It’s important to raise awareness. There is still a stigma in life around mental health. We need to promote that students are individuals with mental health concerns, that they’re not alone and help is available,” says Hiatt. (Picked up by Concord Monitor.)

Read article – An opinion piece co-authored by Steven Woloshin, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice; Paul Glasziou from Bond University; and Susan Michie from University College London, in which they discuss how more research is needed to identify and disseminate the most effective and least disruptive interventions to reduce virus transmission.

Read article – Quotes Kendall Hoyt, assistant professor of medicine, in an article about COVID-19 vaccine distribution and supply challenges.

Read article – Quotes Judith Rees, associate professor of epidemiology, in an article about a study she co-authored which found that 61% of people in New Hampshire plan to get a COVID-19 vaccine once it’s offered to them. Rees said those numbers indicate growing trust in the vaccine among Granite Staters. (Picked up by Monadnock Ledger-Transcript.)

Read article – Quotes Kendall Hoyt, assistant professor of medicine, in an article about COVID-19 vaccine distribution and how wealthy countries have laid claim to more than half the doses that could come on the market by the end of next year. Though wealthy nations have reserved a large number of vaccines, they have to wait to get their orders fulfilled. “Just because you’ve purchased 100 million doses doesn’t mean you’ll get 100 million doses in December,” said Hoyt.

Read article – Quotes James Greenblatt, clinical assistant professor of psychiatry, in an article about how researchers are finding evidence suggesting that genetics is a primary driver in anorexia, bulimia, and binge eating. “It hopefully will change this concept that these are disorders of will and frustration and control,” says Greenblatt. “It does provide a better sense in the community of, okay, this is not your fault. This is not a disorder of control. There is a genetic underlying that triggers this neurobiological process that distorts how your body responds to food and how your brain thinks about your body.”

Read article – Quotes Jennifer Emond, assistant professor of biomedical data science and of pediatrics, about a study she led which found that current gaps in the regulation of commercial educational websites by the U.S. Department of Agriculture are exposing children to unhealthy food advertising. “Our main issue is that if the USDA does not deem products to be nutritious enough to sell in schools, companies shouldn’t be allowed to advertise them on school-issued devices that children now need to use because of the COVID-19 pandemic,” said Emond.

Listen now – As a guest on The Exchange, Kendall Hoyt, assistant professor of medicine, discusses which populations might receive the COVID-19 vaccine first, when that might occur, and how vaccines will be distributed. (Hoyt’s comments begin at approximately 4:30.)

Listen now – Comments by Jose Mercado, assistant professor of medicine, are included in a segment about people who are dealing with the long-term health impacts of COVID-19. Mercado explains that those lasting effects can include heart and lung complications, abnormal blood clotting, the loss of smell and taste, difficulty with concentration, and memory problems. Mercado says that care needs to be decentralized so that doctors and researchers can better understand the range of impacts.

Watch video – Features comments by Elizabeth Talbot, professor of medicine, in a segment about Moderna’s request for emergency authorization of their COVID-19 vaccine. “As a society, as a species, it’s hard to overstate the enthusiasm within the expert community for some of the data we’re seeing right now,” Talbot said. “In terms of safety, in terms of efficacy across age populations.”